U.S. Online Retail and Ecommerce Stock News

In February 2026, Crocs, Inc. reported that fourth-quarter 2025 sales eased to US$957.64 million with net income falling sharply year on year, issued guidance for 2026 revenues to be roughly flat against 2025, and disclosed that it has now repurchased 56.38 million shares for about US$2.97 billion under its long-running buyback. These updates, set against renewed global tariff uncertainty affecting Crocs' international supply chain, highlight a tension between shareholder returns via...

If you are wondering whether Salesforce's current share price lines up with its underlying worth, you are not alone. This article focuses squarely on what you might be paying for compared with what you are getting. After closing at US$178.16, the stock has seen a 6.1% decline over the past week, a 21.9% decline over the last 30 days, a 29.8% decline year to date, and a 41.8% decline over the past year, while its 3 year and 5 year returns sit at 10.5% and a 17.1% decline respectively. These...

If you have been wondering whether Seaboard's US$4,875.78 share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The stock has been volatile recently, with a 9.3% decline over the last 7 days, flat performance over 30 days, and longer term returns of 10.2% year to date and 69.9% over 1 year that may catch your eye. These moves have put Seaboard back on the radar for investors asking whether the current price still lines up with...

Understanding Icahn Enterprises after recent performance Icahn Enterprises (IEP) has been on many investors’ watchlists after a mixed stretch, with the unit price near $7.73 and returns ranging from a 3.3% gain year to date to a 73.1% decline over three years. That gap between shorter term and longer term performance, together with revenue of about $9.3b and a net loss of $391 million, is prompting investors to reassess how the partnership’s diversified businesses are feeding into overall...

Tesla (TSLA) is drawing investor attention after its recent trading session, with the stock closing at $399.83 and showing mixed return patterns over the past week, month, and past 3 months. See our latest analysis for Tesla. The recent 1 day share price return of a 2.91% decline, on top of a 10.96% decline over 30 days and an 8.73% decline year to date, contrasts with Tesla’s 20.97% 1 year total shareholder return and 92.57% 3 year total shareholder return. This suggests near term momentum...

Thermon Group Holdings (THR) has drawn investor attention after its recent share performance, including a return of 17.0% over the past month and 41.3% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Thermon Group Holdings. The recent 17.0% 1 month share price return and 41.3% 3 month share price return have come after a strong run in total shareholder returns, with a 75.2% 1 year total shareholder return suggesting momentum has been building...

Investors may be wondering whether BGC Group’s recent share price really reflects what the business is worth, or if the market is missing something important. The stock closed at US$9.39, with returns of 2.0% over 7 days, 5.4% over 30 days, 5.0% year to date, 6.4% over 1 year and a little over double over 3 and 5 years. This naturally raises questions about how much of that performance is already priced in. Recent coverage has focused on BGC Group’s position in US diversified financials and...

Why Oddity Tech Stock Is Back on Investors’ Radar Interest in Oddity Tech (NasdaqGM:ODD) picked up after Conestoga Capital Advisors highlighted the company in its fourth quarter 2025 investor letter, pointing to rapid scaling, revenue growth, and solid operating margins. See our latest analysis for Oddity Tech. Despite the positive attention from Conestoga, Oddity Tech’s recent trading has been choppy. The 7 day share price return is 6.48%, but the 30 day share price return shows a 15.58%...

Energy Transfer (NYSE:ET) is progressing with two large-scale pipeline expansion projects that reflect strong customer demand and upsized capacity plans. The company has entered into long-term contracts with technology sector clients, including Oracle, tying its midstream assets to growing data center energy needs. Management has outlined higher capital expenditure plans and signaled expectations of higher annual distributions as these projects and contracts advance. For you as an investor,...

Earlier this month, Qualcomm appointed Brett Simpson as senior vice president of Investor Relations and expanded its India footprint through a Tata Electronics automotive manufacturing partnership and a up to US$150 million Strategic AI Venture Fund targeting local deep tech startups. Together, these moves signal Qualcomm’s effort to deepen ties with global technology investors while building a broader AI and automotive ecosystem anchored in India’s emerging semiconductor supply chain. Next,...

CarGurus, NasdaqGS:CARG, has authorized a new $250 million share repurchase program. The company is sharpening its focus on its core marketplace and international growth after winding down CarOffer. Management highlighted strong revenue, record retention, and faster dealer acquisition, including outside the US. CarGurus, trading at $27.86, sits at an interesting crossroads, with a 3-year return of 63.4% and a 5-year return of 5.5%. In the shorter term, the stock is down 18.1% over the past...

BioNTech (NasdaqGS:BNTX) is back on investor radars after recent share price swings, with mixed short and longer term returns prompting a closer look at how its current valuation compares with its fundamentals. See our latest analysis for BioNTech. Recent trading reflects that picture, with a 7 day share price return of 3.83% and a 90 day share price return of 10.25%. Meanwhile, the 1 year total shareholder return is a 6.03% decline, suggesting that momentum has picked up in the short term...

With no single headline event driving attention today, U.S. Bancorp (USB) is drawing interest as investors weigh its recent share performance, current valuation metrics, and the scale of its core banking and payments businesses. See our latest analysis for U.S. Bancorp. U.S. Bancorp’s share price at US$55.81 comes after a 4.86% 1 day share price decline, but a 14.11% 90 day share price return and 27.76% 1 year total shareholder return suggest recent momentum has been generally positive for...

Workday, Inc. (NasdaqGS:WDAY) has appointed co founder Aneel Bhusri as CEO, replacing Carl Eschenbach. The leadership change is tied to an accelerated artificial intelligence strategy across the business. The move signals a potential shift in how Workday prioritizes AI within its product roadmap and investments. Workday focuses on cloud based applications for finance and human resources, serving large enterprises that are rethinking how they manage people, data, and workflows. AI is...

Rocket Lab Corporation recently launched its Cassowary Vex mission on the HASTE rocket for the U.S. Department of War’s Defense Innovation Unit from Wallops Island, Virginia, carrying Hypersonix’s DART AE hypersonic aircraft. This fourth hypersonic test mission in six months highlights Rocket Lab’s expanding role in high-tempo, Mach 20-class defense testing, reinforcing its position in national security-focused launch services. We’ll now explore how this rapid hypersonic testing progress,...

Regulatory catalyst and fresh financials reshape the CRISPR Therapeutics story The FDA’s draft guidance to speed approvals for rare disease genome editing therapies puts CRISPR Therapeutics (CRSP) in sharper focus for many investors, especially alongside its latest earnings update. See our latest analysis for CRISPR Therapeutics. Recent trading reflects a mixed picture, with a 1-day share price return of 0.97% and a 7-day share price return of 1.71%, set against a 1-year total shareholder...

Iovance Biotherapeutics (NasdaqGM:IOVA) reported strong real world clinical data for its commercial therapy Amtagvi in advanced melanoma patients. The data indicate best in class efficacy for a one time T cell therapy in patients who have already tried and failed earlier treatments. Amtagvi is currently the first and only FDA approved treatment of its kind for this late line melanoma setting. Iovance focuses on cell based cancer therapies, with Amtagvi as its flagship product targeting...

Agnico Eagle Mines (NYSE:AEM) has increased its stake in Maple Gold Mines as part of a broader plan focused on external growth. The company has also indicated it is actively looking for additional acquisitions to support long term production goals over the coming decade. This shift toward acquisition driven expansion marks a material change in how Agnico Eagle Mines is looking to grow its portfolio. At a share price of $240.49, NYSE:AEM has seen very strong returns in recent periods,...

CNH Industrial (CNH) is back in focus after recent share price moves, with the stock showing a mix of short term softness and stronger gains over the past month and over the past three months. See our latest analysis for CNH Industrial. The recent pullback, including a 2.53% 1 day share price decline to US$12.73, comes after a strong 30 day share price return of 17% and a 90 day gain of 30.97%. The 1 year total shareholder return of a 0.63% decline and 3 year total shareholder return of a...

If you are wondering whether UniFirst's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. The stock recently closed at US$234.05, with returns of 12.5% over the last 30 days, 20.9% year to date, and 12.2% over the past year. However, the 7 day return of a 2.2% decline and the 5 year return of a 1.3% decline suggest the ride has not been entirely smooth. Recent coverage of UniFirst has focused on the stock's...

Clorox (CLX) has caught investor attention after recent share price moves, with the stock up around 12% over the past month and roughly 19% in the past 3 months. See our latest analysis for Clorox. That recent momentum sits within a more mixed picture, with a 25.69% year to date share price return contrasting with a 14.68% decline in 1 year total shareholder return, so short term sentiment looks stronger than longer term results. If Clorox has you thinking about where else capital could work,...

Elliott Investment Management publicly urged Norwegian Cruise Line Holdings (NYSE:NCLH) to overhaul its board and senior leadership, criticizing past decisions. The campaign coincides with the surprise appointment of John W. Chidsey as CEO, signaling a potential reset at the top of the company. Elliott is pushing for a new business plan and governance changes, working alongside cruise industry veteran Adam Goldstein to support its proposals. Norwegian Cruise Line Holdings, the parent...

If you are wondering whether Zeta Global Holdings is attractively priced or just looks cheap on the surface, this article breaks down what the current share price really implies. The stock closed at US$14.98, with returns of a 3.1% decline over 7 days, a 31.1% decline over 30 days, a 24.8% decline year to date and a 30.7% decline over the past year, while the 3 year return stands at 37.2%. Recent coverage has focused on how Zeta Global is positioning its software and data offerings within...

CDW Corporation (NasdaqGS:CDW) is reorganizing its operations into three customer-focused segments: Commercial, Government, and Education. The company has entered into a new credit agreement that increases its borrowing capacity. CDW has filed a universal shelf registration, giving it the ability to issue a range of securities in the future if it chooses. CDW is a large IT solutions and services provider that sits at the intersection of hardware, software, and cloud needs for business,...